Author:
Strober Bruce,Berger Emily,Cather Jennifer,Cohen David,Crowley Jeffrey J.,Gordon Kenneth B.,Gottlieb Alice,Horn Elizabeth J.,Kavanaugh Arthur F.,Korman Neal J.,Krueger Gerald G.,Leonardi Craig L.,Menter Alan,Schwartzman Sergio,Sobell Jeffrey M.,Young Melodie
Reference301 articles.
1. Systemic effects of local treatment with high doses of potent corticosteroids in psoriatics;Nilsson;Acta Derm Venereol,1979
2. Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment;Rosenberg;J Hepatol,2007
3. The safety of etretinate as long-term therapy for psoriasis: results of the etretinate follow-up study;Stern;J Am Acad Dermatol,1995
4. The pharmacokinetics of etanercept in patients with end-stage renal disease on haemodialysis;Don;J Pharm Pharmacol,2005
5. Safety and efficacy of alefacept in elderly patients and other special populations;Gottlieb;J Drugs Dermatol,2005
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献